Abstract: There is considerable variability in the surgical approach to differentiated thyroid cancer regarding the decision to explore and remove central or central and lateral compartment lymph nodes. Much as sentinel lymph node sampling has improved the decision to remove axillary nodes for breast cancer, vital dye and lymphoscintigraphy with lymph node sampling may direct the surgical approach to differentiated thyroid cancer.
The Concept of Sentinel Lymph Node
The sentinel lymph node (SLN) is defined as the first lymph node to receive drainage from a primary cancer. 1, 2 The concept of SLN is based on the fact that the first lymph node in a lymphatic chain, the SLN, will be the first node affected by metastasis, and if it can be shown to be negative, it is highly unlikely that other nodes are affected. 1, 2 Intraoperative lymphatic mapping with SLN biopsy has become a key component in the management of solid malignancies. 3 The SLN technique is currently used to aid surgery for melanoma and breast cancer, but its use is increasing in other types of solid tumors including differentiated thyroid carcinoma (DTC). [1] [2] [3] The SLN has been developed as an alternative to elective lymph node dissection in patients with clinically node-negative disease, and it is considered to be an accurate technique for obtaining information about cervical lymph node involvement in patients undergoing thyroidectomy. [3] [4] [5] One of the complicating aspects in neck surgery and specifically in thyroid surgery is that the lymphatic drainage pathways are quite intricate. 1 Lymphatic vessels usually accompany blood vessels and nerves in pathways that are not always predictable. Lymphatic vessels draining the thyroid intraglandular capillaries via the capsule may cross-communicate with the isthmus and the opposite lobe. Usually, the superior lymph vessels drain the isthmus and the medial superior portion of the thyroid lobes, ascending anteriorly to the larynx, terminating in subdigastric lymph nodes of the internal jugular chain. Medial inferior lymph vessels descend with the inferior vein to the pretracheal nodes. Lateral collecting lymphatics drain superiorly to the anterior and superior nodes of the internal jugular vein. Numerous classifications have been proposed to describe the location and the anatomic boundaries of lymph node groups in the neck. The most commonly used classification is that of the American Joint Committee on Cancer and the American Academy of Head and Neck Surgery. 6, 7 Lymph Node Metastases in Papillary Thyroid Carcinoma
Patients with papillary thyroid carcinoma (PTC) commonly have lymph node metastases at the time of initial diagnosis and less frequently during successive follow-up. The thyroid gland has an extensive network of draining lymphatics, both intraglandular and extraglandular. 4, 6, 7 Not surprisingly, the central neck compartment is most commonly involved with metastatic disease in patients with PTC; however, lateral and mediastinal compartment disease is also common. 6, 7 Incidence of metastasis is reported between 15% and 50%, but microscopic metastases have been found in up to 80% of patients with PTC. 8 The central compartment (level VI) is involved in approximately 90% of the cases. 8, 9 Lateral compartment lymph node involvement varies between 51% and 100% in different series, with caudal compartments involved more frequently than cranial compartments. 10 Supraclavicular lymph nodes are the third most common site involved in terms of frequency, with a reported rate ranging from 10% to 52%. 9, 11 Contralateral lymph node involvement is not rare with a prevalence of up to 18.4% for PTC. 11, 12 Mediastinal lymph node involvement, mostly the anterosuperior mediastinal nodes, is less frequent at 1.9% to 15%. [9] [10] [11] The distribution of locoregional lymph node involvement is often unrelated to the site of the primary thyroid tumor. Even when the tumor is located in the upper third of the thyroid lobes, subdigastric lymph nodes are often involved. Tumors arising in the isthmus may cause bilateral cervical metastases with major risk of nodal recurrence on the contralateral neck. The size of the primary tumor may be important. Lymph node metastases with PTC smaller than 10 mm are usually found in the paratracheal area and rarely in the jugular nodes. 6, 7 It is important to recognize that the reported prevalence of regional lymphatic metastases identified in PTC patients varies according to the extent of nodal dissection carried out. 2, 4 Prognostic Significance of Lymph Node Metastases in PTC Surgical treatment is considered as the most effective therapy for patients with PTC. It remains controversial whether a prophylactic lymph node dissection improves the prognosis of PTC patients and to what extent lymph node status affects patient survival in PTC. [1] [2] [3] [8] [9] [10] [11] Locoregional lymph node metastases of PTC may carry a worse prognosis, and it is thought that extensive resection can improve the outcome of these patients. Although nodal involvement has little influence on long-term survival of patients with PTC, the presence of extracapsular invasion has been reported to be an indicator of distant metastases and poor prognosis.
The prevalence of lymph node metastases is relatively high in PTC patients, even in the presence of small tumors, and thus it could be suggested that local recurrence rate is reduce by lymph node dissection. On the other hand, generalized dissection of central compartment area may cause important complications, including recurrent laryngeal nerve damage and permanent hypoparathyroidism. Dissection is obviously not necessary in patients with negative lymph nodes.
Thus, SLN sampling can avoid the morbidity associated with unnecessary node dissection.
Surgical Techniques for Neck Dissection in PTC
Currently, the extent of lymph node dissection is based predominantly on histological type, stage of the primary tumor, and preoperative knowledge of nodal involvement. In the presence of gross lymph node involvement, there is no debate about the need and prognostic benefit of a neck dissection in addition to total thyroidectomy. On the other hand, the management of clinically N0 lymph node is generally much more conservative. [1] [2] [3] [4] [5] In the absence of evidence in favor of routine prophylactic neck dissection, some surgeons may consider selective lymphadenectomy or "node picking" of the ipsilateral central compartments. More aggressive approaches suggest routine prophylactic neck dissection in clinically N0 PTC due to high rate of occult lymph node metastasis. Nodal disease may be ultimately demonstrated in 82% of patients with PTC. [1] [2] [3] [4] [5] Methods of SLN Biopsy in PTC
Vital Dye Technique
Early attempts at thyroid chromo-lymphoscintigraphy by chlorophyll and lipiodol ultra-fluid in DTC supported the "sentinel lymph node concept" by showing stained nodes that harbored metastasis. 1 Several studies have described the utilization of vital dye techniques for SLN identification in PTC. This technique has been described in detail. At the time of surgery, vital dye is injected into or around the tumor using a tuberculin syringe (Fig. 1) . The thyroid gland is preferably not extensively mobilized before dye injection so that lymphatic drainage remains intact. Usually within seconds, but sometimes up to 1 to 2 minutes, the blue dye is seen to pass through lymphatic channels toward the SLN (Fig. 2) . Once identified, all blue-stained nodes are removed with extreme caution to avoid accidental removal of parathyroid glands that may have been incidentally stained. After removal, the nodes are submitted for frozen section analysis. Disadvantages of vital dye technique include the following 1 : risk of disruption and interruption of the lymphatic channels from the nodule 2 ; difficulties in identifying SLN lying outside the central compartment 3 ; and requirement to identify the parathyroid glands before injection, 4 the technique is not always easy and requires experience.
Lymphoscintigraphy and Intraoperative γ-Probe Technique
To overcome some of these drawbacks, the authors proposed the use of a combination of a preoperative lymphoscintigraphy using radiocolloids and intraoperative detection with a γ-probe. Lymphoscintigraphy is an excellent method to visualize the lymphatic pathways and the SLN. It offers the following significant advantages over the vital dye technique Tc-nanocolloid particles (particle size, 20-80 nm) in a volume of 0.1 to 0.5 mL of saline. Ultrasound-guided injection is useful for small nodules located deep in the thyroid lobe (Fig. 3) . Peritumoral (PT) injection should be avoided because of the rich vascularity of the thyroid gland with the consequent possible spillage of the radiocolloid outside the gland. Lymphatic drainage from the thyroid gland is monitored by dynamic images (1 frame per 15 seconds, 64 Â 64 matrix) in the anteroposterior projection for up to 10 minutes. Longer acquisition times have been proposed (Fig. 4) . Additional 5-minute static images in anterior, lateral, and oblique views are usually obtained (256 Â 256 matrix) for up to 1 to 3 hours after injection or until FIGURE 1. Intranodular injection of vital dye at surgery. adequate accumulation of the radiocolloid in the SLN is obtained. Surface localization of the SLN is marked with a water-resistant dye.
After a variable interval (2-24 hours), the patient is taken to the operating theater for a total or near total thyroidectomy. After that, a hand-held collimated γ-probe is used to scan the central compartments (through the incision) and the lateral compartments (through skin surface) for "radioactive" lymph nodes (Figs. 5, 6 ). Sentinel lymph node detection has been reported as feasible up to 24 hours after injection. A lesion-to-background ratio of 2:1 or greater is significant for SLN identification, although a smaller threshold level of 10% or 20% is acceptable in breast cancer and melanoma.
Sentinel lymph nodes are selectively excised, and the activity of the lymphatic bed is monitored with a detector probe to verify completeness of surgical extirpation (Fig. 7) . It is important to emphasize that thyroidectomy must precede SLN detection to avoid interference from radioactivity in primary tumor. Finally, the SLN(s) is sent for histopathology to screen for occult metastasis.
Combination of Vital Dye and Lymphoscintigraphy and Intraoperative γ-Probe Techniques
The combination of vital dye, lymphoscintigraphy, and intraoperative γ-probe techniques was described first of all in 2001 by Catarci et al 39 in 6 PTC patients. They used intratumoral (IT) injection of 0.1 mL of 99m Tc-labelled colloidal albumin to visualize the SLN 2 hours before surgery. At surgery, 0.1 mL/cm of tumoral diameter of Patent Blue V (2.5%) was injected directly into the tumor, identified without dividing any structure to preserve the lymphatic drainage.
The SLN identification was obtained by the flow and accumulation of the dye and hand-held γ detection probe. Sentinel lymph nodes were correctly identified in all cases, suggesting that these techniques have a complementary role.
PATIENTS AND METHODS
We completed a search via the PubMed interface on January 20, 2015 for the MeSH headings "sentinel lymph node biopsy" and "thyroid carcinoma." All original retrospective and prospective articles that examined SLN techniques human thyroid carcinoma were reviewed. The full text versions of the studies were obtained for further detailed evaluation. We subdivided the articles on the basis of the technique used to detect the SLN: group 1 included articles describing the technique of SLN with vital dye; group 2 included articles describing the technique of SLN with the radioisotope; and group 3 included articles describing the combined use of the 2 techniques. We extracted data from the articles including the following details: number of patients; preoperative diagnosis; postoperative diagnosis of PTC; SLN technique; in particular use of blue dye, isotope, or both; volume and concentration; site of injection; time of injection; SLN detection rate; and metastatic SLN rate.
Reviews and letters were excluded from these 3 groups. 1, [40] [41] [42] [43] [44] To avoid duplication of patient data in this review, multiple articles from the same authors and institutions were evaluated carefully for possible duplication. If this was thought likely, only the most recent article was included. Moreover, from these 3 groups, we excluded the study of Saliba et al 45 and the study of Maniakas et al. 46 In the first article, in 2014, the authors performed a retrospective chart review of 96 lowrisk PTC patients treated with total thyroidectomy with SLN sampling at the McGill Thyroid Cancer Center. They evaluated the postoperative thyroglobulin level and the status of SLNs. The authors concluded that a correlation exists between SLN and postoperative thyroglobulin. 45 In the second article, Maniakas et al 46 in 2014 performed a retrospective chart review on 311 patients operated for well-differentiated thyroid carcinoma who underwent a total thyroidectomy and SLN biopsy. They compared the patients with positive SLN versus patients with negative SLN, and they concluded that age (<45 years) and higher T category were found to be associated with a higher rate of positive SLNs. 46 
RESULTS
We considered a total of 41 articles from between 1998 and 2014, which examined techniques for SLN detection in thyroid carcinoma. We subdivided the articles on the basis of the type of technique used to detect the SLN in thyroid carcinoma. Vital dye was used in 26 articles, radioisotope in 12 articles, 36,47-57 and combined techniques in 3 articles. 28, 32, 39 Baseline characteristics, methodologies, and results of the studies evaluating vital dye, radioisotope, and combined techniques are shown in Tables 1, 2 , and 3, respectively.
Vital Dye Technique
The number of vital dye patients ranged between a minimum of 9 22 and a maximum of 300. 38 Preoperative diagnosis was DTC in 4 studies 20, 28, 29, 38 and PTC in 21 studies. 13 In 1 study, 22 the injection site was both IT and PT. The SLN was identified in a range between 0% 22 and 100%
13
; the SLN was positive for metastases of PTC in a range between 14% 38 and 86%. 25 
Lymphoscintigraphy and Intraoperative γ-Probe Technique
The number of lymphoscintigraphy patients ranged between a minimum of 1 56 and a maximum of 374. 55 Preoperative diagnosis was DTC in 2 studies 47, 48 and PTC in 8 studies. 36, [49] [50] [51] [52] [53] [54] [55] In 2014, Boni et al 56 and Puccini et al 57 examined, respectively, 1 patient and 4 patients with medullary thyroid carcinoma (MTC). The histological diagnosis of PTC ranged between a minimum of 1 patient 48 and a maximum of 345 patients. 55 The authors used 99m Tc-nanocolloid particles in volumes ranging between 0.1 mL 36, 50, 51, 53, 57 and 0.5 mL. 36, 47 Injection site was IT in 7 studies 47, [50] [51] [52] [53] 56, 57 and PT in 5 studies. 36, 48, 49, 54, 55 The SLN was localized in a range between 64% 51 and 100%. 47, 48, 50, 56, 57 Sentinel lymph nodes were positive for metastases of PTC in a range between 16% 55 and 100%. 48 
Combination of Vital Dye and Lymphoscintigraphy and Intraoperative γ-Probe Techniques
The number of patients examined with combination vital dye and lymphoscintigraphy ranged between a minimum of 6 39 and a maximum of 45. 32 Preoperative diagnosis was DTC in 1 study 28 and PTC in 2 studies. 32, 39 The histological diagnosis of PTC ranged between a minimum of 6 patients 39 and a maximum of 45 patients. 32 Utilized vital dyes included Patent Blue in 1 study 39 and methylene blue in 2 studies. 28, 32 Lymphoscintigraphy was performed with 99m
Tc-nanocolloid particles. 28, 32, 39 Volume of vital dye ranged between 0.1 mL 28 and 1 mL. 32 The injection site was IT in 2 studies 32, 39 and PT in 1 study. 28 The volume of 99m
Tc-nanocolloid ranged between 0.1 mL 28,39 and 0.5 mL. 32 The injection site of 99m Tc-nanocolloid was IT. 28, 32, 39 The SLN was localized in a range between 98% 28 and 100%.
32,39
The SLN was positive for metastases of PTC in a range between 50% 28 and 67%. 39 
DISCUSSION
Sentinel lymph node detection and sampling is well standardized in some tumors, particularly melanoma and breast cancer, and has provided undeniable benefits in their treatment. 1, 40 The use of the SLN in DTC was proposed 17 years ago by Kelemen et al. 13 Since then, its indications, benefits, and limitations have been controversial. 40, 41 Sentinel lymph node sampling is of particular value in PTC because while follicular carcinoma is commonly associated with hematogenous dissemination, PTC usually metastasizes by the lymphatic route. Regarding PTC, the first controversial subject is the prognostic significance of nodal involvement and, thus, the value of accurate staging during surgery. This has led to another controversial consideration, the need for prophylactic lymphadenectomy of the central compartment. [41] [42] [43] Sentinel lymph node sampling may possibly contribute to clarification on this subject in the future. 41 Sampling of SLNs has allowed the detection of microscopic metastatic disease while reducing potential morbidity associated with unhelpful nodal dissections. [40] [41] [42] [43] [44] Sentinel lymph node detection can be performed using vital dye technique, lymphoscintigraphy and γ-probe, and combined techniques. Vital dyes such as methylene blue, isosulfan blue, and Patent Blue V have a high affinity for lymphatic tissue. The dye is injected in or around the tumor at surgery. After a few minutes, the dye drains to one or several lymph nodes, which will be easily identified by their change in color. During injection, inadvertent spillage of the dye may cause problems in identification of SLN, recurrent laryngeal nerve, and parathyroid glands. 1, 24, [40] [41] [42] [43] [44] With lymphoscintigraphy, a radioactive isotope is injected in or around the tumor. 36, [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] Typically, a 99m
Tc-labeled nanocolloid molecule of an adequate size (50-800 nm) embolizes in the first lymph node and remains there long enough to be detected. Subsequently, scintigraphic images are taken, and at surgery, a γ-probe is used to locate the SLN.
36,47-57 Lymphoscintigraphy appears to be more precise for SLN localization compared with vital dye visual techniques, although there are some limitations to intraoperative isotope procedures. [40] [41] [42] [43] According to most reported series, SLNs are localized in 80% to 90% of the cases with vital dye and in 95% to 100% of the cases with isotopic procedure. Some authors have suggested that a combination of both procedures provides an even better yield. 28, 32, 39 Nonvisualization of lymphatics and SLNs is well recognized with both 43 (14) NA, data not available; US-g, ultrasound guidance. (53) NA, data not available; US-g, ultrasound guidance; RP, radiopharmaceutical.
techniques. [40] [41] [42] [43] [44] This is variously explained by lymphatic disruption during exposure of the thyroid nodule, blockage of lymphatics by tumor, or lymphatics leading to sites with limited surgical access, such as retroesophageal or retrothyroid locations. Sentinel lymph nodes may occasionally be located in areas that are relatively inaccessible via a collar incision. This has been reported with both lymphoscintigraphy and vital dye techniques. 28, 32, 39 Specific to the lymphoscintigraphy is the requirement to remove the thyroid gland before identification of the SLN because of so called shine-through effect. This is due to the close proximity of thyroid and central compartment lymph nodes to the thyroid nodule where the radioisotope is injected.
This review demonstrates that there is sufficient preliminary evidence to support the need for a more rigorous assessment of the SLN technique in thyroid cancer. In PTC, involvement of cervical lymph nodes at the time of surgery is very high and is even greater when micrometastases are considered. 41 The use of SLN sampling has also allowed for establishing that nodal metastases are more common than are suspected preoperatively. [40] [41] [42] [43] 
